Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (73)	3/12/1998 12:56:00 PM
From: aknahow	Respond to of 4974

Sorry I was not clear. I assume he is managing his own funds in the same biotech stocks he is buying for the partnership funds. Understand my assumption can be wrong but my point was it is easier, (but still painful), to be patient with ones own funds but another level of risk comes from the pressure of clients who may not understand the area and withdraw their funds forcing sales at the "wrong" time.

To: scaram(o)uche who wrote (73)	3/13/1998 9:25:00 AM
From: scaram(o)uche	Read Replies (2) \| Respond to of 4974

I've mentioned Amerindo previously, and their role in the troubled biotech market of early '97. Other funds were virtually dumping shares, in fear that Amerindo would encounter margin calls. So, here's a link for Connetics (CNCT)...... biz.yahoo.com Now, follow this link and drag the graph's scroll bar to the left until you reach January through April, 1997....... amerindo.com Ask yourself..... why in the world would CNCT brag that Amerindo has chosen them for an investment?